Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Use of Biomarkers in Drug Development for Regulatory Purposes
Use of Biomarkers in Drug Development for Regulatory Purposes
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Robert N. Schuck
,
Vanitha Sekar
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Clinical and Translational Science
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.70377
Similar Items
From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model‐Informed Drug Development ( MIDD )
by: Issam Zineh
Published: (2026)
Navigating Drug–Drug Interactions in Clinical Drug Development: A Tutorial
by: Jesmin Lohy Das, et al.
Published: (2025)
Predicting Pharmacokinetic Variability and Drug Interaction Risk Using Omics‐Based Biomarkers
by: Bhagwat Prasad
Published: (2026)
A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications
by: Matthew Wiens, et al.
Published: (2025)
Clinical Significance of Drug–Drug Interaction Studies During Therapeutic Peptide Drug Development: Follow‐Up Investigation of Therapeutic Peptides Approved Between 2021 and 2024
by: Carolina Säll, et al.
Published: (2025)